Organization | University of Tasmania

University of Tasmania Report issue

Academic/Hospital

Organization Overview

First Clinical Trial

2013

NCT02396160

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2019

Timeline

NOW

Now

Alternative names

University of Tasmania

Active Ingredients

Drugs in Other Trials (4)

crateva nurvala stem bark (1 trial)

epoetin (Epogen) (1 trial)

equisetum arvense sp (1 trial)

lindera aggregata root (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 2
# of Trial APIs: 4